Comparison
2p13 2 Microdeletion Syndrome C4749460 vs 14q12 Microdeletion Syndrome C4305240
Clinical comparison between 2p13 2 Microdeletion Syndrome and 14q12 Microdeletion Syndrome for differential diagnosis and treatment planning.
2p13 2 Microdeletion Syndrome C4749460
A rare chromosomal condition where a small segment is missing from chromosome 2. Features vary based on which genes are affected. Care focuses on addressing specific symptoms.
14q12 Microdeletion Syndrome C4305240
A rare chromosomal condition where a segment of chromosome 14 is missing. It may cause developmental delays and other health concerns. Treatment is supportive and individualized.
6 comparison axes
Onset
2p13 2 Microdeletion Syndrome C4749460
0-0
14q12 Microdeletion Syndrome C4305240
0-1
Onset patterns differ
Severity
2p13 2 Microdeletion Syndrome C4749460
severe
14q12 Microdeletion Syndrome C4305240
moderate
Different severity levels
Chronic
2p13 2 Microdeletion Syndrome C4749460
Chronic
14q12 Microdeletion Syndrome C4305240
Chronic
Differing course
Communicable
2p13 2 Microdeletion Syndrome C4749460
No
14q12 Microdeletion Syndrome C4305240
No
Different transmission
Body System
2p13 2 Microdeletion Syndrome C4749460
congenital
14q12 Microdeletion Syndrome C4305240
congenital
Same/different system
Category
2p13 2 Microdeletion Syndrome C4749460
rare-disease
14q12 Microdeletion Syndrome C4305240
genetic
Different category
Bottom line
2p13-2-microdeletion-syndrome-C4749460 and 14q12-microdeletion-syndrome-C4305240 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2p13 2 Microdeletion Syndrome C4749460 | 14q12 Microdeletion Syndrome C4305240 | Discriminating power |
|---|---|---|---|
| Developmental concerns | May occur, but specific pattern is not established here. | Developmental delay is described as a possible feature. | Low |
| Overall clinical severity | Recorded as severe, with features depending on affected genes. | Recorded as moderate, with variable health concerns. | Moderate |
| Age at recognition | Supplied onset is coded 0-0, suggesting very early recognition. | Supplied onset is coded 0-1, suggesting early infancy recognition. | Low |
When to favor each condition
Choose 2p13 2 Microdeletion Syndrome C4749460 when
Genetic testing identifies a deletion at 2p13.2
The chromosomal location defines this condition rather than symptoms alone.
High
A severe congenital presentation needs syndrome-specific labeling
The source records severe severity, but individual findings still require review.
Moderate
Care planning follows confirmed gene content
Features vary with affected genes, so management should be individualized.
Moderate
Choose 14q12 Microdeletion Syndrome C4305240 when
Genetic testing identifies a deletion at 14q12
The chromosomal region is the defining distinction.
High
Developmental delay is the main reported concern
This is explicitly mentioned for the 14q12 condition.
Moderate
A moderate congenital chromosomal diagnosis is being documented
The source records moderate severity, without establishing all outcomes.
Moderate
How key tests differ
| Test | 2p13 2 Microdeletion Syndrome C4749460 | 14q12 Microdeletion Syndrome C4305240 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May show a deletion involving 2p13.2. | May show a deletion involving 14q12. | The genomic location distinguishes the conditions; clinician and laboratory confirmation is required. |
| Karyotype | May miss a small deletion. | May miss a small deletion. | A normal karyotype does not exclude either microdeletion. |
| Targeted gene or region testing | Useful only if the 2p13.2 region is assessed. | Useful only if the 14q12 region is assessed. | A negative targeted test does not exclude a deletion outside its scope. |
Prognosis comparison
2p13 2 Microdeletion Syndrome C4749460
- Outcome
- Long-term outcome is not established; the source records a severe chronic congenital condition.
- Factors
- Affected genes and individual clinical findings may influence needs.
14q12 Microdeletion Syndrome C4305240
- Outcome
- Long-term outcome is not established; moderate severity and developmental concerns are recorded.
- Factors
- The extent of the deletion and associated health issues may influence support needs.
Time frame: Lifelong course is suggested, but exact milestones are not established.
Prognosis should be individualized; mortality and prevalence are not provided.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental impairment | Possible but not specifically characterized here. Developmental delay is a stated possible concern. Neither source establishes severity, timing, or permanence for every person. |
| Associated health problems | Variable according to affected genes. Other health concerns may occur. Specific organ complications are not established by the supplied descriptions. |
| Need for long-term support | Chronic course is recorded. Chronic course is recorded. Support needs should be based on individual assessment, not diagnosis alone. |
Patient education highlights
- HighDiagnosis
These are distinct chromosomal findings; a test result should be interpreted by a genetics clinician.
- HighVariability
Features can differ between people, and the available descriptions do not list definitive symptoms.
- MediumCare
Treatment is supportive and individualized; no specific medicine or dose is established here.